mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.1 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.1 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.1 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.1 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.049 |
0.1 |